In some cases, GS disrupts normal eating patterns, which can lead to poorer glycaemic control and potentially life‐threatening hypoglycaemia in patients with insulin‐treated or sulphonylurea‐treated diabetes (DM).6, 7. The gene discussed is INS; the disease is diabetes mellitus.